View in EDS

Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.

Saved in:
Bibliographic Details
Title: Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.
Authors: Shrestha S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Tapper EE; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Trogstad-Isaacson CS; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Hobday TJ; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Offer SM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA., Diasio RB; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA.
Source: JCO precision oncology [JCO Precis Oncol] 2018; Vol. 2. Date of Electronic Publication: 2018 Oct 03.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2473-4284 (Print) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32039342
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shrestha+S%22">Shrestha S</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Tapper+EE%22">Tapper EE</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Trogstad-Isaacson+CS%22">Trogstad-Isaacson CS</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Hobday+TJ%22">Hobday TJ</searchLink>; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Offer+SM%22">Offer SM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA.<br /><searchLink fieldCode="AU" term="%22Diasio+RB%22">Diasio RB</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2018; Vol. 2. <i>Date of Electronic Publication: </i>2018 Oct 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2473-4284 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32039342
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/po.18.00179
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shrestha S
      – PersonEntity:
          Name:
            NameFull: Tapper EE
      – PersonEntity:
          Name:
            NameFull: Trogstad-Isaacson CS
      – PersonEntity:
          Name:
            NameFull: Hobday TJ
      – PersonEntity:
          Name:
            NameFull: Offer SM
      – PersonEntity:
          Name:
            NameFull: Diasio RB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2018
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 2473-4284
          Numbering:
            – Type: volume
              Value: 2
          Titles:
            – TitleFull: JCO precision oncology
              Type: main
ResultId 1